DHA Patient Safety Guidelines 2 — Questions and Answers

Question 1: The DHA Patient Safety Framework includes which internationally recognized patient safety goals as mandatory standards for licensed facilities?

ACGME core competencies for physician training
JCI International Patient Safety Goals (IPSGs) adopted and mandated by DHA (Correct answer)
WHO Global Burden of Disease priorities only
NICE guidelines from the UK National Health Service

Correct answer: JCI International Patient Safety Goals (IPSGs) adopted and mandated by DHA

DHA has adopted JCI International Patient Safety Goals (IPSGs) as mandatory standards for all licensed healthcare facilities in Dubai. The IPSGs address the most critical patient safety risks: correct identification, communication, high-alert medications, surgery/procedure safety, infection prevention, and fall prevention.

JCI IPSGs (DHA mandatory): IPSG 1 — Identify patients correctly (2 identifiers); IPSG 2 — Improve communication among caregivers (SBAR, critical value reporting); IPSG 3 — Improve safety of high-alert medications; IPSG 4 — Ensure correct-site, correct-procedure, correct-patient surgery (time out, surgical checklist); IPSG 5 — Reduce risk of healthcare-associated infections (hand hygiene); IPSG 6 — Reduce risk of patient harm from falls (fall risk assessment, prevention interventions). DHA inspections verify compliance with all IPSGs. Deficiencies in IPSGs are immediate findings requiring corrective action.

Question 2: Under DHA patient safety regulations, all healthcare facilities must have a functional incident reporting system. What is the primary goal of such a system?

To identify staff for disciplinary action when errors occur
To collect data for malpractice defense by the facility
To create a learning culture where incidents, near misses, and unsafe conditions are reported and analyzed to prevent recurrence (Correct answer)
To generate statistics for marketing the hospital as 'error-free'

Correct answer: To create a learning culture where incidents, near misses, and unsafe conditions are reported and analyzed to prevent recurrence

The primary purpose of incident reporting systems is to build a learning culture for patient safety improvement. By analyzing incidents (including near-misses where no harm occurred), organizations identify system failures and implement preventive changes. A punitive culture suppresses reporting and hides safety risks.

Effective incident reporting system characteristics: voluntary and mandatory reporting categories (serious incidents = mandatory); non-punitive (just culture); anonymous reporting option; timely review and feedback to reporters; root cause analysis for sentinel events; system-level corrective actions; aggregate analysis for trends; shared learning across the organization. Near-miss reporting is especially valuable — near misses occur 300× more frequently than serious events but identify the same system failures. WHO patient safety: healthcare reporting systems are most effective when linked to improvement, not punishment. DHA incident reporting connects to national safety learning systems.

Question 3: In the context of DHA patient safety and medication management, what is the 'tall-man lettering' technique?

Using larger fonts for prescription labels in pharmacy
Using mixed case letters to differentiate similar drug names (e.g., hydrALAZINE vs. hydrOXYzine) to prevent LASA errors (Correct answer)
Writing drug doses in capital letters to emphasize dose
Printing medication labels in red for high-alert drugs

Correct answer: Using mixed case letters to differentiate similar drug names (e.g., hydrALAZINE vs. hydrOXYzine) to prevent LASA errors

Tall-man lettering uses mixed case (with capital letters highlighting the distinguishing parts of similar drug names) to visually differentiate LASA pairs. Example: DOBUTamine vs. DOPamine; chlorproMAZINE vs. chlorproPAMIDE. This technique reduces dispensing and administration errors with look-alike sound-alike medications.

ISMP and FDA have published recommended tall-man lettering lists. Examples: hydrALAZINE/hydrOXYzine, predniSONE/prednisoLONE, vinBLAStine/vinCRIStine, CARBOplatin/CISplatin, DAUNOrubicin/DOXOrubicin. Implementation: EHR order entry screens, pharmacy dispensing labels, drug storage labels, medication administration records. DHA pharmacies must implement tall-man lettering for identified LASA pairs. Combined with storage separation and clinical decision support alerts, it significantly reduces LASA-related medication errors. Staff education on LASA risks is also required.

Question 4: A patient allergic to penicillin is prescribed cefazolin for surgical prophylaxis. The allergy is documented as 'rash.' What is the appropriate clinical decision?

Absolute contraindication — avoid all cephalosporins and use vancomycin
The risk of cross-reactivity is low (1–2%); cefazolin is generally considered safe in patients with non-severe penicillin allergy (not anaphylaxis/SJS); assess allergy history carefully (Correct answer)
Always use vancomycin regardless of allergy severity
Skip surgical prophylaxis entirely due to the allergy

Correct answer: The risk of cross-reactivity is low (1–2%); cefazolin is generally considered safe in patients with non-severe penicillin allergy (not anaphylaxis/SJS); assess allergy history carefully

Cross-reactivity between penicillins and cephalosporins is low (~1–2%). Patients with a history of mild reactions (rash) to penicillin can generally receive cephalosporins. Only patients with history of anaphylaxis, SJS/TEN, or other severe immediate reactions require avoidance of cephalosporins. The allergy history should be carefully reviewed.

Penicillin cross-reactivity with cephalosporins: historical teaching 10% cross-reactivity was overstated; current evidence: ~1–2% true cross-reactivity, mainly for structurally similar side chains (not the beta-lactam ring). Management: minor reactions (rash, GI) — cephalosporins generally safe (especially cefazolin which has different side chain from ampicillin); anaphylaxis, urticaria, SJS/TEN to penicillin — avoid beta-lactams or perform allergy testing. For surgical prophylaxis in penicillin anaphylaxis: clindamycin (gram-positive coverage for skin) or vancomycin. Document allergy assessment and clinical decision-making.

Question 5: What is the recommended first step when a healthcare worker suspects a medical device malfunction that may have caused or could cause patient harm?

Continue using the device to confirm the malfunction
Immediately remove the device from service, label it 'DO NOT USE,' report to biomedical engineering and the risk management department, and file an incident report (Correct answer)
Repair the device independently at bedside
Wait until the device fails completely before reporting

Correct answer: Immediately remove the device from service, label it 'DO NOT USE,' report to biomedical engineering and the risk management department, and file an incident report

When a device malfunction is suspected: immediately take the device out of service to prevent further harm, label clearly to prevent use by others, notify biomedical engineering for inspection, report to risk management (and potentially DHA Medical Devices department), and file an incident/adverse event report. Device should be preserved for investigation — do not discard or repair before investigation.

Medical device adverse event management: Immediate: remove from service, preserve device as-is for investigation (do not clean or repair), label 'DEVICE FAILURE — DO NOT USE'; Short-term: biomedical engineering inspection, incident report, risk management notification; Regulatory: DHA Medical Products Division regulates medical devices in Dubai — report device-related patient harm; Manufacturer: report to manufacturer for recall investigation; Learning: analyze event, determine if system-wide issue with similar devices. Medical devices in UAE: registered by MOHAP/DHA, post-market surveillance required. Vigilance reporting by healthcare professionals is mandatory for device-related serious adverse events.

Question 6: In DHA-licensed facilities, 'informed consent' for surgical procedures must be obtained by whom?

The ward nurse before the patient goes to theatre
Any hospital employee designated by the facility
The operating surgeon (or another physician who has the training and knowledge to explain the procedure and its risks) (Correct answer)
The anesthesiologist for all surgical procedures

Correct answer: The operating surgeon (or another physician who has the training and knowledge to explain the procedure and its risks)

Informed consent for a specific surgical procedure must be obtained by the physician with the knowledge and training to explain that procedure — typically the operating surgeon. The surgeon must personally explain the procedure, alternatives, risks, and benefits. Nurses can witness and document consent but cannot substitute for the physician in obtaining it.

Informed consent responsibilities: Surgeon: explain procedure, material risks (common and serious), benefits, alternatives (including no treatment), expected outcome; must use language patient understands; must be obtained without time pressure or coercion. Anesthesiologist: obtains separate consent for anesthesia. Nurse role: witness signature, verify patient understanding, document in record — cannot explain surgical details or risk-benefit analysis. Timing: must be obtained well before procedure (not in holding area when patient is anxious/medicated). Emergency exception: if patient incapacitated and no next-of-kin, emergency implied consent applies — document clearly. DHA and JCI audit consent documentation as a key requirement.

DHA Patient Safety Guidelines 2

The DHA Patient Safety Framework includes which internationally recognized patient safety goals as mandatory standards for licensed facilities?